CAMG
CWA Asset Management Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,425
| Closed | -$205K | – | 534 |
|
|
2023
Q4 | $205K | Buy |
+3,425
| New | +$205K | 0.01% | 401 |
|
|
2023
Q3 | – | Sell |
-3,400
| Closed | -$310K | – | 357 |
|
|
2023
Q2 | $310K | Hold |
3,400
| – | – | 0.02% | 276 |
|
|
2023
Q1 | $224K | Buy |
+3,400
| New | +$224K | 0.02% | 290 |
|
|
2022
Q4 | – | Sell |
-4,000
| Closed | -$273K | – | 320 |
|
|
2022
Q3 | $273K | Sell |
4,000
-1,000
| -20% | -$68.3K | 0.03% | 244 |
|
|
2022
Q2 | $226K | Buy |
+5,000
| New | +$226K | 0.02% | 267 |
|
|
2021
Q1 | – | Sell |
-4,000
| Closed | -$229K | – | 275 |
|
|
2020
Q4 | $229K | Buy |
+4,000
| New | +$229K | 0.02% | 237 |
|